Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial

por Lebbé, Celeste, Meyer, Nicolas, Mortier, Laurent, Marquez-Rodas, Ivan, Robert, Caroline, Rutkowski, Piotr, Menzies, Alexander M., Eigentler, Thomas, Ascierto, Paolo A., Smylie, Michael, Schadendorf, Dirk, Ajaz, Mazhar, Svane, Inge Marie, Gonzalez, Rene, Rollin, Linda, Lord-Bessen, Jennifer, Saci, Abdel, Grigoryeva, Elena, Pigozzo, Jacopo
Publicado 2019